Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms

Area of Science:

• Transplant immunology
• Nephrology
• Vascular biology

Background:

• Antibody-mediated rejection (AMR) is a primary cause of chronic transplant rejection and graft loss.
• Mechanisms of AMR beyond complement activation are increasingly recognized, including Fc-independent antibody functions.
• C4d-negative AMR highlights the role of antibodies in endothelial activation and dysfunction.

Purpose of the Study:

• To review current clinical trends in AMR, including microvascular inflammation and antibody targets.
• To discuss the functional characterization of antibodies and their mechanisms of endothelial and smooth muscle cell activation.
• To explore the interplay between antibodies, complement, and T-cell immunity in AMR.

Main Methods:

• Review of current clinical trends in AMR.
• Analysis of antibody prevalence (HLA-DQ, non-HLA targets).
• Functional characterization of HLA IgG subclasses and complement-fixing capacity.
• Examination of experimental evidence on antibody-induced cell activation.
• Discussion of antibody-complement-T-cell interactions.

Main Results:

• Microvascular inflammation is a key feature in AMR biopsies.
• Antibodies targeting HLA-DQ and non-HLA antigens are prevalent.
• Both complement-dependent and complement-independent antibody mechanisms contribute to graft injury.
• New mechanisms of endothelial and smooth muscle cell activation by HLA antibodies are identified.

Conclusions:

• Complement-fixing antibodies have prognostic value, but complement-independent mechanisms are crucial in AMR.
• Therapeutic strategies targeting antibody-induced endothelial activation show promise for ameliorating AMR.
• Understanding these mechanisms is vital for improving long-term allograft survival.